Probiotics Reduce the Risk of Antibiotic-Associated Diarrhea in Adults (18-64 Years) but Not the Elderly (>65 Years)

Nutrition in Clinical Practice

Volumn 31, Issue 4, 2016, Pages 502-513

  Jafarnejad, Sadegh ^a   Shab Bidar, Sakineh ^a   Speakman, John R ^b   Parastui, Karim ^a   Daneshi Maskooni, Milad ^a   Djafarian, Kurosh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

adults; aged; antibiotic associated diarrhea; diarrhea; elderly; probiotics

Indexed keywords

PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

AGE; ANTIBIOTIC ASSOCIATED DIARRHEA; DRUG EFFICACY; HUMAN; LACTOBACILLUS; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SACCHAROMYCES BOULARDII; ADOLESCENT; ADULT; AGED; CHEMICALLY INDUCED; DIARRHEA; MIDDLE AGED; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DIARRHEA; HUMANS; MIDDLE AGED; PROBIOTICS; RISK; YOUNG ADULT;

EID: 84978731798     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533616639399     Document Type: Review

References (55)

1. McFarland LV,. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006; 101 (4): 812-822.
2. Beaugerie L, Petit JC,. Microbial-gut interactions in health and disease: antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol. 2004; 18 (2): 337-352.
3. McFarland LV,. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008; 3 (5): 563-578.
4. McFarland LV,. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis. 1998; 16 (5): 292-307.
5. Pilotto A, Franceschi M, Vitale D, et al. The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol. 2008; 103 (11): 2816-2823.
6. Surawicz CM,. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol. 2003; 17 (5): 775-783.
7. Iapichino G, Callegari ML, Marzorati S, et al. Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol. 2008; 57 (pt 8): 1007-1014.
8. Walk ST, Young VB,. Emerging insights into antibiotic-associated diarrhea and Clostridium difficile infection through the lens of microbial ecology. Interdiscip Perspect Infect Dis. 2008; 2008: 125081.
9. Venkatasubramani N, Rudolph CD, Sood MR,. Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study. BMC Gastroenterol. 2008; 8: 38.
10. Aslam S, Musher DM,. An update on diagnosis, treatment, and prevention of Clostridium difficile -associated disease. Gastroenterol Clin North Am. 2006; 35 (2): 315-335.
11. Pattani R, Palda VA, Hwang SW, Shah PS,. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 2013; 7 (2): e56-e67.
12. Snydman DR,. The safety of probiotics. Clin Infect Dis. 2008; 46 (suppl 2): S104-S111.
13. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L rhamnosus GG. Clin Infect Dis. 2004; 38 (1): 62-69.
14. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012; 307 (18): 1959-1969.
15. Szajewska H, Ruszczynski M, Radzikowski A,. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006; 149 (3): 367-372.
16. McFarland LV,. Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections. Benef Microbes. 2015; 6 (2): 189-194.
17. Szajewska H, Mrukowicz J,. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2005; 22 (5): 365-372.
18. Videlock EJ, Cremonini F,. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2012; 35 (12): 1355-1369.
19. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4: 1.
20. Allen SJ, Wareham K, Wang D, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013; 382 (9900): 1249-1257.
21. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2001; 15 (2): 163-169.
22. Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A,. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006; 12 (4): Pi19-Pi22.
23. Chatterjee S, Kar P, Das T, et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India. 2013; 61 (10): 708-712.
24. Cimperman L, Bayless G, Best K, et al. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol. 2011; 45 (9): 785-789.
25. Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S,. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter. 2007; 12 (4): 309-316.
26. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2002; 16 (8): 1461-1467.
27. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE,. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile -associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010; 105 (7): 1636-1641.
28. Gotz V, Romankiewicz JA, Moss J, Murray HW,. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm. 1979; 36 (6): 754-757.
29. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007; 335 (7610): 80.
30. Koning CJ, Jonkers D, Smidt H, Rombouts F, Pennings HJ, Wouters E, et al. The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. Br J Nutr. 2010; 103 (10): 1452-1460.
31. Lonnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I,. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010; 44 (2): 106-112.
32. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995; 90 (3): 439-448.
33. Myllyluoma E, Veijola L, Ahlroos T, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy: a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther. 2005; 21 (10): 1263-1272.
34. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004; 20 (10): 1181-1188.
35. Orrhage K, Brismar B, Nord CE,. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis. 1994; 7 (1): 17-25.
36. Ouwehand AC, DongLian C, Weijian X, et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine. 2014; 32 (4): 458-463.
37. Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2012; 107 (6): 922-931.
38. Safdar N, Barigala R, Said A, McKinley L,. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans. J Clin Pharm Ther. 2008; 33 (6): 663-668.
39. Selinger CP, Bell A, Cairns A, Lockett M, Sebastian S, Haslam N,. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J Hosp Infect. 2013; 84 (2): 159-165.
40. Song HJ, Kim JY, Jung SA, et al. Effect of probiotic Lactobacillus (Lacidofil(R) cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci. 2010; 25 (12): 1784-1791.
41. Souza DN, Jorge MT,. The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial. Rev Soc Bras Med Trop. 2012; 45 (1): 112-116.
42. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G,. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989; 96 (4): 981-988.
43. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM,. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc. 2001; 76 (9): 883-889.
44. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J,. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr. 2008; 62 (2): 299-301.
45. Wong S, Jamous A, O'Driscoll J, et al. A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial. Br J Nutr. 2014; 111 (4): 672-678.
46. Wright K, Wright H, Murray M,. Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients: a multicentre randomised controlled pilot study. Australas J Ageing. 2015; 34 (1): 38-42.
47. Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrugger RW,. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol. 2008; 103 (1): 178-189.
48. Sampalis J, Psaradellis E, Rampakakis E,. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea: a placebo controlled double-blind randomized, multi-center study. Arch Med Sci. 2010; 6 (1): 56-64.
49. Beausoleil M, Fortier N, Guenette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007; 21 (11): 732-736
50. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA,. Probiotics inhibit enteropathogenic E coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol. 1999; 276 (4, pt 1): G941-G950.
51. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology. 2004; 126 (5): 1358-1373.
52. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA,. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003; 52 (10): 1442-1447.
53. Petrof EO, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 2004; 127 (5): 1474-1487.
54. Servin AL,. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28 (4): 405-440.
55. Guslandi M,. Are probiotics effective for treating Clostridium difficile disease and antibiotic-associated diarrhea? Nat Clin Pract Gastroenterol Hepatol. 2006; 3 (11): 606-607.